To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of medication for Parkinson's disease produced by Teva Pharmaceuticals.
This answer is the replacement for a previous holding answer.
Answered on
9 September 2024
Teva Pharmaceuticals supply a range of medicines to treat Parkinson’s disease. We are not aware of any issues with Teva Pharmaceuticals’ supply of these medicines. Teva Pharmaceuticals discontinued amantadine 100 milligram capsules in July 2024, however alternative suppliers remain in stock, and are able to meet patient demand.
Answered by
Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.